US Stock MarketDetailed Quotes

Fortress Biotech (FBIO)

Watchlist
  • 3.480
  • +0.200+6.10%
Close Jan 15 16:00 ET
108.01MMarket Cap-29.00P/E (TTM)

Fortress Biotech (FBIO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
20.52%17.63M
10.18%16.41M
0.84%13.14M
-31.76%57.68M
-24.20%15.12M
-57.90%14.63M
-14.32%14.9M
4.84%13.03M
11.58%84.51M
21.59%19.95M
Operating revenue
16.38%17.03M
0.76%15.01M
0.84%13.14M
-12.80%56.68M
-29.21%14.12M
-5.57%14.63M
-13.27%14.9M
5.24%13.03M
-11.05%64.99M
21.93%19.95M
Cost of revenue
28.72%5.76M
-13.76%4.94M
-20.19%4.79M
-8.80%20.88M
108.19%4.68M
-30.46%4.47M
-26.26%5.73M
-6.93%6M
-25.61%22.89M
-70.87%2.25M
Gross profit
16.91%11.88M
25.14%11.47M
18.80%8.35M
-40.29%36.8M
-41.01%10.44M
-64.14%10.16M
-4.68%9.17M
17.53%7.03M
37.03%61.62M
103.75%17.7M
Operating expense
-42.06%18.69M
39.75%47.95M
-29.66%30.67M
-26.28%148.04M
1.27%37.79M
-23.35%32.25M
-39.36%34.31M
-32.77%43.59M
-19.20%200.82M
-41.07%37.31M
Selling and administrative expenses
-20.82%17.42M
86.13%38.76M
43.04%25.66M
-3.57%87.73M
37.98%26.86M
1.20%21.99M
-14.80%20.82M
-29.20%17.94M
-19.95%90.98M
-30.96%19.47M
Research and development costs
-97.80%208K
-35.87%8.13M
-84.15%3.94M
-46.37%56.88M
-29.38%9.94M
-53.58%9.45M
-60.58%12.67M
-37.13%24.84M
-21.36%106.07M
-59.92%14.08M
Depreciation amortization depletion
30.71%1.06M
30.71%1.06M
30.84%1.07M
-9.11%3.42M
--981K
--814K
--814K
--814K
--3.77M
----
-Depreciation and amortization
30.71%1.06M
30.71%1.06M
30.84%1.07M
-9.11%3.42M
--981K
--814K
--814K
--814K
--3.77M
----
Operating profit
69.17%-6.81M
-45.09%-36.47M
38.97%-22.32M
20.09%-111.24M
-39.42%-27.35M
-60.60%-22.1M
46.47%-25.14M
37.88%-36.57M
31.62%-139.2M
64.10%-19.61M
Net non-operating interest income expense
64.31%-2.01M
-36.60%-1.9M
-30.86%-2.32M
11.92%-10.84M
-52.96%-2.07M
-182.84%-5.62M
75.69%-1.39M
45.74%-1.77M
-0.56%-12.31M
66.68%-1.35M
Non-operating interest income
24.96%736K
-15.26%622K
-41.18%490K
-10.66%2.68M
-25.60%526K
7.68%589K
2.66%734K
-19.59%833K
114.81%3M
2.91%707K
Non-operating interest expense
8.01%2.42M
39.10%2.07M
25.94%2.51M
-2.74%11.59M
287.33%5.87M
19.13%2.24M
-71.34%1.49M
-39.97%1.99M
14.38%11.92M
-49.83%1.52M
Total other finance cost
-91.77%327K
-29.64%444K
-51.56%295K
-42.97%1.94M
-701.84%-3.27M
504.72%3.97M
-48.41%631K
-37.60%609K
5.43%3.4M
-68.46%544K
Other net income (expense)
1,521.10%17.67M
1,263.04%26.72M
91.42%-59K
172.62%1.54M
144.96%3.43M
-78.88%1.09M
65.35%-2.3M
-109.85%-688K
-190.53%-2.12M
-550.35%-7.64M
Gain on sale of security
-110.53%-2K
-600.00%-350K
92.95%-47K
-114.42%-638K
99.05%-60K
-99.58%19K
113.67%70K
-109.99%-667K
291.85%4.42M
---6.28M
Special income (charges)
--0
1,124.05%27.13M
----
127.39%861K
--3.51M
--0
59.32%-2.65M
----
---3.14M
--0
-Less:Impairment of capital assets
----
----
----
17.47%3.69M
--1.04M
--0
-15.72%2.65M
----
--3.14M
--0
-Less:Other special charges
----
----
----
---4.55M
----
----
----
----
----
----
-Write off
--0
--0
----
17.47%3.69M
--1.04M
--0
-15.72%2.65M
----
--3.14M
--0
-Gain on sale of business
--0
--27.13M
----
----
----
--0
--0
----
----
----
Other non- operating income (expenses)
1,550.05%17.67M
-121.99%-62K
42.86%-12K
138.73%1.32M
98.82%-16K
72.74%1.07M
-28.61%282K
-106.91%-21K
-380.08%-3.4M
-338.80%-1.35M
Income before tax
133.25%8.85M
59.57%-11.65M
36.73%-24.69M
21.54%-120.54M
9.18%-25.98M
-151.58%-26.63M
51.39%-28.82M
29.24%-39.02M
28.03%-153.63M
49.81%-28.61M
Income tax
-62.32%26K
-40.12%312K
-11.35%336K
-51.06%69K
16.04%521K
-15.59%379K
Net income
133.07%8.83M
59.57%-11.65M
36.73%-24.69M
21.60%-120.86M
9.21%-26.32M
-148.92%-26.69M
51.39%-28.82M
29.24%-39.02M
27.94%-154.15M
49.54%-28.98M
Net income continuous Operations
133.07%8.83M
59.57%-11.65M
36.73%-24.69M
21.60%-120.86M
9.21%-26.32M
-148.92%-26.69M
51.39%-28.82M
29.24%-39.02M
27.94%-154.15M
49.54%-28.98M
Minority interest income
121.53%2.98M
-51.82%-27.14M
40.24%-14.11M
19.95%-74.86M
0.79%-19.55M
-143.48%-13.83M
48.22%-17.88M
29.76%-23.61M
26.56%-93.52M
35.39%-19.71M
Net income attributable to the parent company
145.47%5.85M
241.45%15.49M
31.35%-10.58M
24.14%-46M
27.09%-6.77M
-155.04%-12.87M
55.81%-10.95M
28.42%-15.42M
29.96%-60.64M
65.57%-9.28M
Preferred stock dividends
0.05%2.17M
-10.87%2.13M
-12.74%2.13M
23.17%9.89M
43.77%2.89M
8.22%2.17M
19.55%2.39M
2.44M
0.00%8.03M
0.00%2.01M
Other preferred stock dividends
300.00%400K
-300K
Net income attributable to common stockholders
124.43%3.68M
200.12%13.36M
28.80%-12.72M
18.61%-55.89M
14.49%-9.65M
-113.24%-15.04M
50.44%-13.34M
24.15%-17.86M
27.42%-68.67M
61.02%-11.29M
Basic earnings per share
117.11%0.13
168.49%0.5
53.85%-0.48
68.24%-2.69
50.94%-0.26
19.15%-0.76
80.00%-0.73
70.03%-1.04
46.96%-8.47
86.52%-0.53
Diluted earnings per share
114.47%0.11
161.64%0.45
53.85%-0.48
68.24%-2.69
50.94%-0.26
19.15%-0.76
80.00%-0.73
70.03%-1.04
46.96%-8.47
86.52%-0.53
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 20.52%17.63M10.18%16.41M0.84%13.14M-31.76%57.68M-24.20%15.12M-57.90%14.63M-14.32%14.9M4.84%13.03M11.58%84.51M21.59%19.95M
Operating revenue 16.38%17.03M0.76%15.01M0.84%13.14M-12.80%56.68M-29.21%14.12M-5.57%14.63M-13.27%14.9M5.24%13.03M-11.05%64.99M21.93%19.95M
Cost of revenue 28.72%5.76M-13.76%4.94M-20.19%4.79M-8.80%20.88M108.19%4.68M-30.46%4.47M-26.26%5.73M-6.93%6M-25.61%22.89M-70.87%2.25M
Gross profit 16.91%11.88M25.14%11.47M18.80%8.35M-40.29%36.8M-41.01%10.44M-64.14%10.16M-4.68%9.17M17.53%7.03M37.03%61.62M103.75%17.7M
Operating expense -42.06%18.69M39.75%47.95M-29.66%30.67M-26.28%148.04M1.27%37.79M-23.35%32.25M-39.36%34.31M-32.77%43.59M-19.20%200.82M-41.07%37.31M
Selling and administrative expenses -20.82%17.42M86.13%38.76M43.04%25.66M-3.57%87.73M37.98%26.86M1.20%21.99M-14.80%20.82M-29.20%17.94M-19.95%90.98M-30.96%19.47M
Research and development costs -97.80%208K-35.87%8.13M-84.15%3.94M-46.37%56.88M-29.38%9.94M-53.58%9.45M-60.58%12.67M-37.13%24.84M-21.36%106.07M-59.92%14.08M
Depreciation amortization depletion 30.71%1.06M30.71%1.06M30.84%1.07M-9.11%3.42M--981K--814K--814K--814K--3.77M----
-Depreciation and amortization 30.71%1.06M30.71%1.06M30.84%1.07M-9.11%3.42M--981K--814K--814K--814K--3.77M----
Operating profit 69.17%-6.81M-45.09%-36.47M38.97%-22.32M20.09%-111.24M-39.42%-27.35M-60.60%-22.1M46.47%-25.14M37.88%-36.57M31.62%-139.2M64.10%-19.61M
Net non-operating interest income expense 64.31%-2.01M-36.60%-1.9M-30.86%-2.32M11.92%-10.84M-52.96%-2.07M-182.84%-5.62M75.69%-1.39M45.74%-1.77M-0.56%-12.31M66.68%-1.35M
Non-operating interest income 24.96%736K-15.26%622K-41.18%490K-10.66%2.68M-25.60%526K7.68%589K2.66%734K-19.59%833K114.81%3M2.91%707K
Non-operating interest expense 8.01%2.42M39.10%2.07M25.94%2.51M-2.74%11.59M287.33%5.87M19.13%2.24M-71.34%1.49M-39.97%1.99M14.38%11.92M-49.83%1.52M
Total other finance cost -91.77%327K-29.64%444K-51.56%295K-42.97%1.94M-701.84%-3.27M504.72%3.97M-48.41%631K-37.60%609K5.43%3.4M-68.46%544K
Other net income (expense) 1,521.10%17.67M1,263.04%26.72M91.42%-59K172.62%1.54M144.96%3.43M-78.88%1.09M65.35%-2.3M-109.85%-688K-190.53%-2.12M-550.35%-7.64M
Gain on sale of security -110.53%-2K-600.00%-350K92.95%-47K-114.42%-638K99.05%-60K-99.58%19K113.67%70K-109.99%-667K291.85%4.42M---6.28M
Special income (charges) --01,124.05%27.13M----127.39%861K--3.51M--059.32%-2.65M-------3.14M--0
-Less:Impairment of capital assets ------------17.47%3.69M--1.04M--0-15.72%2.65M------3.14M--0
-Less:Other special charges ---------------4.55M------------------------
-Write off --0--0----17.47%3.69M--1.04M--0-15.72%2.65M------3.14M--0
-Gain on sale of business --0--27.13M--------------0--0------------
Other non- operating income (expenses) 1,550.05%17.67M-121.99%-62K42.86%-12K138.73%1.32M98.82%-16K72.74%1.07M-28.61%282K-106.91%-21K-380.08%-3.4M-338.80%-1.35M
Income before tax 133.25%8.85M59.57%-11.65M36.73%-24.69M21.54%-120.54M9.18%-25.98M-151.58%-26.63M51.39%-28.82M29.24%-39.02M28.03%-153.63M49.81%-28.61M
Income tax -62.32%26K-40.12%312K-11.35%336K-51.06%69K16.04%521K-15.59%379K
Net income 133.07%8.83M59.57%-11.65M36.73%-24.69M21.60%-120.86M9.21%-26.32M-148.92%-26.69M51.39%-28.82M29.24%-39.02M27.94%-154.15M49.54%-28.98M
Net income continuous Operations 133.07%8.83M59.57%-11.65M36.73%-24.69M21.60%-120.86M9.21%-26.32M-148.92%-26.69M51.39%-28.82M29.24%-39.02M27.94%-154.15M49.54%-28.98M
Minority interest income 121.53%2.98M-51.82%-27.14M40.24%-14.11M19.95%-74.86M0.79%-19.55M-143.48%-13.83M48.22%-17.88M29.76%-23.61M26.56%-93.52M35.39%-19.71M
Net income attributable to the parent company 145.47%5.85M241.45%15.49M31.35%-10.58M24.14%-46M27.09%-6.77M-155.04%-12.87M55.81%-10.95M28.42%-15.42M29.96%-60.64M65.57%-9.28M
Preferred stock dividends 0.05%2.17M-10.87%2.13M-12.74%2.13M23.17%9.89M43.77%2.89M8.22%2.17M19.55%2.39M2.44M0.00%8.03M0.00%2.01M
Other preferred stock dividends 300.00%400K-300K
Net income attributable to common stockholders 124.43%3.68M200.12%13.36M28.80%-12.72M18.61%-55.89M14.49%-9.65M-113.24%-15.04M50.44%-13.34M24.15%-17.86M27.42%-68.67M61.02%-11.29M
Basic earnings per share 117.11%0.13168.49%0.553.85%-0.4868.24%-2.6950.94%-0.2619.15%-0.7680.00%-0.7370.03%-1.0446.96%-8.4786.52%-0.53
Diluted earnings per share 114.47%0.11161.64%0.4553.85%-0.4868.24%-2.6950.94%-0.2619.15%-0.7680.00%-0.7370.03%-1.0446.96%-8.4786.52%-0.53
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More